Literature DB >> 3107569

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity.

D A Cooney, G Ahluwalia, H Mitsuya, A Fridland, M Johnson, Z Hao, M Dalal, J Balzarini, S Broder, D G Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3107569     DOI： 10.1016/0006-2952(87)90235-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  29 in total

Review 1.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Metabolism of 2',3'-dideoxyinosine (ddI) in human blood.

Authors:  D J Back; S Ormesher; J F Tjia; R Macleod
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro.

Authors:  P G Hoggard; V Manion; M G Barry; D J Back
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

4.  Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1.

Authors:  R F Schinazi; J P Sommadossi; V Saalmann; D L Cannon; M Y Xie; G C Hart; G A Smith; E F Hahn
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 5.  Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Authors:  F Kamali
Journal:  Clin Investig       Date:  1993-05

Review 6.  Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.

Authors:  J Balzarini
Journal:  Pharm World Sci       Date:  1994-04-15

Review 7.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

8.  Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.

Authors:  E F Terwilliger; B Godin; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosine.

Authors:  Tudor M Griffith; Andrew T Chaytor; David H Edwards; Felice Daverio; Christopher McGuigan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

10.  Nonlinear disposition of intravenous 2',3'-dideoxyinosine in rats.

Authors:  M G Wientjes; E Mukherji; J L Au
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.